default author photo

Thaddeus W. Egondi

Drugs for Neglected Diseases Initiative (DNDi)

SCHOLARLY PAPERS

1

DOWNLOADS

128

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Two Dose Levels of Once-Weekly Fosravuconazole Versus Daily Itraconazole, in Combination with Surgery, in Patients with Eumycetoma in Sudan: A Randomised, Double-Blind, Phase 2, Proof-of-Concept Superiority Trial

Number of pages: 20 Posted: 22 Apr 2024
University of Khartoum - Mycetoma Research Centre, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, University of Khartoum, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Bruno Scherrer Conseil, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Eisai Ltd., Uppsala University, Uppsala University, Radboud University Nijmegen - Radboud University Medical Center, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi) and Drugs for Neglected Diseases Initiative (DNDi)
Downloads 128 (572,948)

Abstract:

Loading...

mycetoma, eumycetoma, Madurella mycetomatis, randomised controlled trial, phase II, fosravuconazole, ravuconazole, itraconazole, Sudan